126 related articles for article (PubMed ID: 11996828)
21. Localization of the thiorphan-sensitive endopeptidase, termed enkephalinase A, on glial cells.
Lentzen H; Palenker J
FEBS Lett; 1983 Mar; 153(1):93-7. PubMed ID: 6337881
[TBL] [Abstract][Full Text] [Related]
22. Oral absorption of peptides: influence of pH and inhibitors on the intestinal hydrolysis of leu-enkephalin and analogues.
Friedman DI; Amidon GL
Pharm Res; 1991 Jan; 8(1):93-6. PubMed ID: 2014216
[TBL] [Abstract][Full Text] [Related]
23. Co-localization of hypocretin-1 and leucine-enkephalin in hypothalamic neurons projecting to the nucleus of the solitary tract and their effect on arterial pressure.
Ciriello J; Caverson MM; McMurray JC; Bruckschwaiger EB
Neuroscience; 2013 Oct; 250():599-613. PubMed ID: 23912034
[TBL] [Abstract][Full Text] [Related]
24. Spinal ERK2 activation through δ2-opioid receptors contributes to nociceptive behavior induced by intrathecal injection of leucine-enkephalin.
Komatsu T; Katsuyama S; Mizoguchi H; Sakurada C; Tsuzuki M; Sakurada S; Sakurada T
Peptides; 2014 Apr; 54():131-9. PubMed ID: 24480726
[TBL] [Abstract][Full Text] [Related]
25. Aminopeptidase activity in human nasal mucosa.
Ohkubo K; Baraniuk JN; Hohman R; Merida M; Hersh LB; Kaliner MA
J Allergy Clin Immunol; 1998 Nov; 102(5):741-50. PubMed ID: 9819290
[TBL] [Abstract][Full Text] [Related]
26. Transport and metabolism of delta sleep-inducing peptide in cultured human intestinal epithelial cell monolayers.
Augustijns PF; Borchardt RT
Drug Metab Dispos; 1995 Dec; 23(12):1372-8. PubMed ID: 8689946
[TBL] [Abstract][Full Text] [Related]
27. Inactivation of enkephalin by brain enzymes.
Vogel Z; Altstein M
Prog Biochem Pharmacol; 1980; 16():49-59. PubMed ID: 7003599
[TBL] [Abstract][Full Text] [Related]
28. Transformations of bioactive peptides in the presence of sugars--characterization and stability studies of the adducts generated via the Maillard reaction.
Roscić M; Horvat S
Bioorg Med Chem; 2006 Jul; 14(14):4933-43. PubMed ID: 16563774
[TBL] [Abstract][Full Text] [Related]
29. Binding to opioid receptors of enkephalin derivatives taking alpha-helical conformation and its dimer.
Sasaki-Yagi Y; Kimura S; Imanishi Y
Int J Pept Protein Res; 1991 Oct; 38(4):378-84. PubMed ID: 1665842
[TBL] [Abstract][Full Text] [Related]
30. Mechanistic appraisal of the effects of some protease inhibitors on ciliary beat frequency in a sequential cell culture system of human nasal epithelium.
Remigius UA; Jorissen M; Willems T; Kinget R; Verbeke N
Eur J Pharm Biopharm; 2003 May; 55(3):283-9. PubMed ID: 12754002
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of neuropeptide loaded trimethyl chitosan nanoparticles for nose to brain delivery.
Kumar M; Pandey RS; Patra KC; Jain SK; Soni ML; Dangi JS; Madan J
Int J Biol Macromol; 2013 Oct; 61():189-95. PubMed ID: 23831532
[TBL] [Abstract][Full Text] [Related]
32. Stability of oxymethyl-modified coumarinic acid cyclic prodrugs of diastereomeric opioid peptides in biological media from various animal species including human.
Liederer BM; Borchardt RT
J Pharm Sci; 2005 Oct; 94(10):2198-206. PubMed ID: 16136552
[TBL] [Abstract][Full Text] [Related]
33. Optically active aromatic amino acids. Part VI. Synthesis and properties of (Leu5)-enkephalin analogues containing O-methyl-L-tyrosine1 with ring substitution at position 3'.
Arnold ZS; Schiller PW
J Pept Sci; 2000 Jun; 6(6):280-9. PubMed ID: 10912908
[TBL] [Abstract][Full Text] [Related]
34. Transport kinetics of leucine enkephalin across Caco-2 monolayers: quantitative analysis for contribution of enzymatic and transport barrier.
Quan YS; Fujita T; Tohara D; Tsuji M; Kohyama M; Yamamoto A
Life Sci; 1999; 64(14):1243-52. PubMed ID: 10210267
[TBL] [Abstract][Full Text] [Related]
35. Effects of amino acid chirality and the chemical linker on the cell permeation characteristics of cyclic prodrugs of opioid peptides.
Liederer BM; Fuchs T; Vander Velde D; Siahaan TJ; Borchardt RT
J Med Chem; 2006 Feb; 49(4):1261-70. PubMed ID: 16480263
[TBL] [Abstract][Full Text] [Related]
36. Blood-brain barrier permeability to leucine-enkephalin, D-alanine2-D-leucine5-enkephalin and their N-terminal amino acid (tyrosine).
Zlokovic BV; Begley DJ; Chain-Eliash DG
Brain Res; 1985 Jun; 336(1):125-32. PubMed ID: 3891014
[TBL] [Abstract][Full Text] [Related]
37. Met-enkephalin-Arg6-Gly7-Leu8 exists together with Met-enkephalin-Arg6-Phe7, Met-enkephalin and Leu-enkephalin in human stomach.
Sakamoto M; Nakao K; Yoshimasa T; Ikeda Y; Suda M; Yanaihara N; Imura H
Life Sci; 1983; 33 Suppl 1():81-4. PubMed ID: 6664255
[TBL] [Abstract][Full Text] [Related]
38. Further characterization of the in vitro hydrolysis of [Leu]- and [Met]enkephalin in rat plasma: HPLC-ECD measurement of substrate and metabolite concentrations.
Shibanoki S; Weinberger SB; Ishikawa K; Martinez JL
Regul Pept; 1991 Feb; 32(3):267-78. PubMed ID: 1678195
[TBL] [Abstract][Full Text] [Related]
39. Studies on the transport of enkephalin-like oligopeptides in rat intestinal mucosa.
Kerchner GA; Geary LE
J Pharmacol Exp Ther; 1983 Jul; 226(1):33-8. PubMed ID: 6345754
[TBL] [Abstract][Full Text] [Related]
40. The effect of glycation on the chemical and enzymatic stability of the endogenous opioid peptide, leucine-enkephalin, and related fragments.
Jakas A; Horvat S
Bioorg Chem; 2004 Dec; 32(6):516-26. PubMed ID: 15530992
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
